Enliven Therapeutics(ELVN.US)

Event Tracking

Dec11

Enliven Therapeutics, Inc. Receives Significant Funding

21:43

Nov16

Candriam S.C.A. Invests in Enliven Therapeutics, Inc.

09:41

Nov14

H.C. Wainwright Reiterates Buy Rating on Enliven Therapeutics

15:56

Nov13

Enliven Therapeutics released FY2025 Q3 earnings on November 12, 2025 (EST), with actual revenue USD 0 (forecast USD 0) and actual EPS USD 0 (forecast USD -0.4362)

04:00

Enliven Therapeutics released FY2025 9 Months earnings on November 12 (EST), actual revenue USD 0, actual EPS USD -1.381

04:00

Nov3

Syed Recommends Enliven Therapeutics Stock with a Buy Rating

21:06

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -20.15 M, EPS -0.3244

Aug13

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -25.34 M, EPS -0.4862

May14

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -28.54 M, EPS -0.5702

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change